KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Revenue (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -2.04%
Dec 28, 2025 2.38%
Sep 28, 2025 1.05%
Jun 29, 2025 8.45%
Mar 30, 2025 -2.78%
Dec 29, 2024 0.22%
Sep 29, 2024 0.11%
Jun 30, 2024 4.98%
Mar 31, 2024 -0.06%
Dec 31, 2023 0.21%
Oct 1, 2023 -0.78%
Jul 2, 2023 2.99%
Apr 2, 2023 4.79%
Jan 1, 2023 -0.29%
Oct 2, 2022 -1.08%
Jul 3, 2022 1.89%
Oct 3, 2021 0.11%
Jul 4, 2021 4.44%
Apr 4, 2021 -0.69%
Jan 3, 2021 6.61%
Sep 27, 2020 14.98%
Jun 28, 2020 -11.38%
Mar 29, 2020 -0.27%
Dec 29, 2019 0.09%
Sep 29, 2019 0.81%
Jun 30, 2019 2.70%
Mar 31, 2019 -1.83%
Dec 30, 2018 0.23%
Sep 30, 2018 -2.31%
Jul 1, 2018 4.10%
Apr 1, 2018 -0.92%
Dec 31, 2017 2.77%
Oct 1, 2017 4.30%
Jul 2, 2017 6.04%
Apr 2, 2017 -1.88%
Jan 1, 2017 1.60%
Oct 2, 2016 -3.58%
Jul 3, 2016 5.72%
Apr 3, 2016 -1.85%
Jan 3, 2016 4.15%
Sep 27, 2015 -3.85%
Jun 28, 2015 2.38%
Mar 29, 2015 -4.82%
Dec 28, 2014 -1.15%
Sep 28, 2014 -5.27%
Jun 29, 2014 7.62%
Mar 30, 2014 -1.31%
Dec 29, 2013 4.44%
Sep 29, 2013 -1.69%
Jun 30, 2013 2.13%
Mar 31, 2013 -0.30%
Dec 30, 2012 2.97%
Sep 30, 2012 3.50%
Jul 1, 2012 2.08%
Apr 1, 2012 -0.71%
Jan 1, 2012 1.56%
Oct 2, 2011 -3.57%
Jul 3, 2011 2.62%
Apr 3, 2011 3.38%
Jan 2, 2011 4.42%
Oct 3, 2010 -2.27%
Jul 4, 2010 -1.93%
Apr 4, 2010 -5.56%
Jan 3, 2010 9.75%
Sep 27, 2009 -1.04%
Jun 28, 2009 1.42%